Trial record 1 of 1 for:
CN1-101
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CN1
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04418141 |
|
Recruitment Status :
Recruiting
First Posted : June 5, 2020
Last Update Posted : July 28, 2020
|
Sponsor:
Curon Biopharmaceutical (Australia) Co Pty Ltd
Collaborator:
Novotech (Australia) Pty Limited
Information provided by (Responsible Party):
Curon Biopharmaceutical (Australia) Co Pty Ltd
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | February 2022 |
| Estimated Study Completion Date : | April 2022 |